Saundra Pelletier, CEO, Evofem Biosciences
Saundra Pelletier is CEO of Evofem Biosciences, a San Diego-based, clinical-stage biopharmaceutical company developing and commercializing innovative products to address unmet needs in women’s sexual and reproductive health. Evofem is leveraging its proprietary Multipurpose Vaginal pH Regulator (MVP-R) to develop product candidates for multiple indications, including contraception, the prevention of transmission of chlamydia and gonorrhea in women, and recurrent bacterial vaginosis. Ms. Pelletier has over 25 years of extensive pharmaceutical, drug and medical device industry experience in both U.S. and global markets.